ASCO: Telomeres and Cancer | GenomeWeb

ASCO: Telomeres and Cancer

Premium

At ASCO this week, Nobel laureate Elizabeth Blackburn chaired session during which she presented her work on telomeres and cancer. Telomeres, the regions of DNA at the ends of chromosomes, protect chromosomes from deteriorating or fusing with one another. When telomeres erode away, cells die, Blackburn said. Telomerase, the enzyme that continually adds DNA to the ends of telomeres to replenish them, has been implicated in cancer, as it makes cells "immortal" and allows them to grow out of control. But by mutating telomerase, researchers can make those cells mortal, Blackburn said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.